Business Context and Reporting Period
Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Operations: UHS operates 367 inpatient facilities and 61 outpatient/other facilities across 39 U.S. states, Washington D.C., the U.K., and Puerto Rico. The company operates through two reportable segments: Acute Care Hospital Services and Behavioral Health Care Services.
Key Financial Metrics
| Metric | Q2 2025 | Q2 2024 | 6M 2025 | 6M 2024 |
|---|---|---|---|---|
| Net Revenues | $4.28 billion | $3.91 billion | $8.38 billion | $7.75 billion |
| Net Income Attributable to UHS | $353.2 million | $289.2 million | $669.9 million | $551.0 million |
| Diluted EPS | $5.43 | $4.26 | $10.23 | $8.08 |
| Operating Income | $500.3 million | $436.4 million | $955.1 million | $825.2 million |
| Operating Margin | 11.7% | 11.2% | 11.4% | 10.6% |
| Net Cash from Operating Activities | N/A | N/A | $909.0 million | $1.08 billion |
| Total Debt (Carrying Value) | $4.6 billion | N/A | $4.6 billion | $4.5 billion |
| Cash and Cash Equivalents | $137.6 million | N/A | $137.6 million | $126.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 9.6% in Q2 2025 and 8.2% for the six months ended June 30, 2025, compared to the prior year. Growth was driven by a 7.2% to 8.4% increase in "Same Facility" revenues and contributions from two newly opened acute care hospitals (West Henderson Hospital in Nevada and Cedar Hill Regional Medical Center in Washington, D.C.).
- Profitability: Net income attributable to UHS increased 22% in both Q2 and the six-month period. Operating margins expanded due to revenue growth outpacing expense increases and a significant reduction in interest expense.
- Interest Expense: Interest expense decreased 28% in Q2 and 26% for the six months ended June 30, 2025. This reduction resulted from a lower average cost of borrowings (4.1% in 2025 vs. 5.0% in 2024) and lower average outstanding borrowings following debt refinancing in September 2024.
- Segment Performance:
- Acute Care: Same facility revenues increased 7.9% (Q2) and 7.2% (6M). Income before taxes increased 19% (Q2) and 25% (6M).
- Behavioral Health: Same facility revenues increased 8.9% (Q2) and 7.3% (6M). Income before taxes increased 11% (Q2) and 9.2% (6M).
Guidance, Outlook, Risks, and Unusual Items
- Capital Expenditures: UHS expects to spend approximately $950 million to $1.1 billion on capital expenditures for the full year 2025. Approximately $505 million was spent in the first six months, with an expected $445 million to $595 million remaining for the year.
- Legislative Impact (OBBBA): The "One Big Beautiful Bill Act" enacted on July 4, 2025, introduces work requirements for Medicaid eligibility and limits on provider taxes. Management estimates this legislation will reduce aggregate annual net benefit from Medicaid supplemental programs by approximately $360 million to $400 million by 2032, phased in starting in fiscal year 2028.
- Legal Proceedings:
- Pavilion Behavioral Health: A $475 million punitive damage verdict (reduced to $120 million) was settled in Q2 2025. The settlement amount was covered by commercial insurance and existing reserves.
- Cumberland Hospital: Multi-plaintiff litigation regarding sexual misconduct by a former medical director resulted in a jury verdict of $360 million (reduced to $1.05 million in punitive damages by the court). Approximately 40 additional plaintiffs remain. Management notes potential material adverse impact if insurance coverage is exhausted.
- Insurance Reserves: No adjustments were recorded to self-insured professional and general liability reserves during the first six months of 2025. However, effective March 2025, commercial insurance coverage terms became less favorable, including exclusions for sexual molestation/abuse and lower aggregate limits.
- Stock Repurchases: During Q2 2025, the company repurchased approximately 875,000 shares for $150.8 million. Approximately $492.9 million remains available under the repurchase program.
Investor Verification Checklist
- Medicaid Revenue Sustainability: Verify the specific impact of the July 2025 "One Big Beautiful Bill Act" on state-specific supplemental payment programs (e.g., Texas CHIRP, Nevada SDP) and the timeline for provider tax reductions.
- Legal Exposure: Monitor the status of the Cumberland Hospital litigation and the potential exhaustion of the remaining $147 million in commercial insurance coverage for the 2020 policy year.
- Interest Rate Sensitivity: Assess the impact of future interest rate fluctuations on the variable-rate portion of the $1.3 billion revolving credit facility and $1.2 billion Term Loan A.
- Capital Allocation: Track the execution of the $950 million to $1.1 billion capital expenditure plan, specifically the ramp-up of the new Washington D.C. and Las Vegas facilities.
- Days Sales Outstanding (DSO): Note that DSO was 50 days at June 30, 2025, compared to 51 days in the prior year, despite a $159 million unfavorable change in accounts receivable cash flow due to timing of Medicaid directed payments.